Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
06/2010
06/24/2010US20100159006 Improved antimicrobial peptides
06/24/2010US20100158937 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid
06/24/2010US20100158885 Method and material for site activated complexing of biologic molecules
06/24/2010US20100158849 Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
06/24/2010US20100155590 Labeled transition metal complexes
06/23/2010CN101750486A Method for labeling antibody by fluorophore generated by combination of iridium coordination compound and histidine
06/22/2010US7741431 Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/17/2010US20100152418 Switch-Peptides as Tool for the Study of Fibrillogenesis
06/17/2010US20100152417 Fluorescent Amino Acid Derivatives
06/17/2010US20100151111 Polypeptides of Strain Bacillus SP. P203
06/17/2010US20100151065 Use of a cosmetic composition for combating the effects of electromagnetic waves on the skin
06/17/2010US20100151003 Egfr binding peptides and uses thereof
06/16/2010EP2195332A1 Modulators of hypersensitivity reactions
06/16/2010CN1908007B Extraction method of plant total protein and special extract for the same
06/16/2010CN101736065A Method for preparing polypeptide by beer sediment
06/16/2010CN101736064A Process for preparing immune reinforcement peptide for enzymolysis on ocean shell and application thereof
06/10/2010US20100145006 Supravalent compounds
06/10/2010US20100144846 Oligoribonucleotides and uses thereof
06/10/2010US20100144637 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
06/10/2010US20100144589 Methods of predicting cancer lethality using replikin counts
06/10/2010US20100143964 Compositions and methods for concentrating and depleting microorganisms
06/10/2010US20100143390 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
06/10/2010US20100143387 Multimeric conjugate
06/10/2010US20100143258 Tumor margin imaging agents
06/09/2010EP2194383A1 Monitoring immunologic, hematologic and inflammatory diseases
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/03/2010WO2010014236A3 Acylhydrazone-based cleavable linkers
06/03/2010US20100138944 Methods of Reducing Repeat-Induced Silencing of Transgene Expression and Improved Fluorescent Biosensors
06/03/2010US20100137557 Use of one or more metal carriers to selectively kill mammalian cells
06/03/2010US20100137222 Basic Peptides and Their Use as Combined Antibacterial-Antifungine Agents
06/03/2010US20100137187 Glutamate-Enhanced Cell-Penetrating Peptides and Methods of Using Same
06/03/2010US20100137186 Use of an active principle originating from amaranth (amaranthus) for preparing a composition intended to activate cellular energy and to protect the skin from oxidative damage
06/03/2010US20100136588 Methods and Devices for Diagnosis of Appendicitis
06/03/2010US20100136567 Cyanine dyes
06/03/2010US20100135951 Agents and Methods Related to Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
06/03/2010US20100135948 Anti-Autoimmune Antibodies for Treatment of Pemphigus
06/02/2010CN101717806A Integrated peptidoglycan and preparation method thereof
06/02/2010CN101717431A Spinach protein extract and application thereof
06/01/2010US7727727 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
05/2010
05/27/2010US20100132059 Temperature-induced polynucleotides and uses therefor
05/27/2010US20100130429 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
05/27/2010US20100129933 Method for detecting the binding between mdm2 and the proteasome
05/27/2010US20100129931 Anti-Methylation-Controlled J Protein Antibodies and Uses Thereof
05/27/2010US20100129869 Methods and compositions for inactivating glutamine synthetase gene expression
05/27/2010US20100129860 Methods of producing the cellulolytic enhancing activity of a polypeptide
05/27/2010CA2743177A1 Peptidomimetic macrocycles with improved properties
05/26/2010CN101712975A Deodorized fish peptide and preparation method thereof
05/25/2010US7723477 Frizzled receptor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
05/20/2010US20100124757 Gold nanoparticle based protease imaging probes and use thereof
05/19/2010CN101709321A Oat polypeptide, preparation method thereof and application thereof
05/19/2010CN101709076A Method for preparing hoof nail polypeptide
05/18/2010US7718772 Canine thymic stromal lymphopoietin protein and uses thereof
05/18/2010US7718766 Fluorescence resonance energy transfer (Fret) on substrates comprising a donor fluorophore; an acceptor having an absorbance spectrum overlapping the emission spectrum of the donor fluorophore; and a clostridial toxin recognition sequence; for clostridium and tetanus toxins
05/14/2010WO2010054212A1 Engineered antibodies with reduced immunogenicity and methods of making
05/14/2010WO2010053518A2 Methods and compositions for inactivating glutamine synthetase gene expression
05/14/2010CA2742861A1 Engineered antibodies with reduced immunogenicity and methods of making
05/14/2010CA2742782A1 Endothelium mimicking nanomatrix
05/13/2010US20100120700 Methods and compositions for treating cervical cancer
05/13/2010US20100119588 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza
05/13/2010US20100119539 Vaccine against malaria, based on the 200l subuniti of plasmodium vivax msp1 protein
05/13/2010US20100119483 Peptide viral entry inhibitors
05/12/2010CN1962690B Oxya chinensis(Thunberg) imago antibacterial protein preparation method
05/06/2010US20100113695 High capacity non-viral vectors
05/06/2010US20100113353 Method and composition for inhibiting cardiovascular cell proliferation
05/06/2010US20100113342 Antimicrobial kinocidin compositions and methods of use
05/06/2010US20100113337 Method for reducing incidence or rate of development of skin cancers and related conditions
05/06/2010US20100113333 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
05/06/2010US20100113327 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein
05/06/2010US20100113326 Dimeric iap inhibitors
05/06/2010US20100112591 Tumor Suppressor Gene
05/06/2010US20100112585 Method for Enriching Methylated CpG Sequences
05/06/2010US20100111992 Cytomegalovirus peptides and methods of use thereof
05/06/2010US20100111949 Methods and compositions for the treatment of proliferative diseases
05/04/2010US7709608 Substrates useful for FRET protease assays for botulinum serotype A/E toxins
04/2010
04/29/2010WO2010048582A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
04/29/2010WO2010045723A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
04/29/2010US20100105864 Prophylactic or therapeutic agent for diarrhea
04/29/2010US20100105602 Treatment of intracellular bacterial infections
04/29/2010US20100104594 Pathogen for bacterial poultry disease
04/29/2010US20100104580 Altered Immunogenic Landscape in HIV-1 Envelope Proteins
04/29/2010CA2778170A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
04/29/2010CA2742043A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
04/28/2010EP2178896A1 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
04/22/2010US20100098688 Method for diagnosis of a disease involving an anti-at1-receptor antibody
04/22/2010US20100098656 Polyamino acids functionalized by hydrophobic grafts bearing an anionic charge and applications thereof, such as therapeutic applications
04/22/2010US20100098636 Compositions for Delivery of Therapeutics and Other Materials
04/21/2010EP1635692B1 Monitoring immunologic, hematologic and inflammatory diseases
04/15/2010US20100093973 Poly(amino acid) compound having inhibitory activity on absorption of phosphorus and phosphorus absorption inhibitor
04/15/2010US20100093600 Regulation of neurotransmitters sequestration and release through manipulation of the vesicular functions
04/15/2010US20100093108 Lung cancer diagnotic assay
04/15/2010US20100092651 Method for fractionating oat, products thus obtained, and use thereof
04/15/2010US20100092481 Human cytomegalovirus neutralising antibodies and use thereof
04/15/2010US20100092386 System for delivering therapeutic agents into living cells and cells nuclei
04/14/2010EP2173759A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses
04/13/2010US7696312 Non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, therapeutic, diagnostic, and other biotechnology uses
04/13/2010US7696307 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS)
04/08/2010WO2010039899A2 Method for monitoring intracellular tyrosine phosphatase activity
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 48